Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
5.10
-0.03 (-0.49%)
Jul 15, 2026, 1:03 PM EDT - Market open
Precigen Market Cap
Precigen has a market cap or net worth of $1.82 billion as of July 15, 2026. Its market cap has increased by 333.31% in one year.
Market Cap
1.82B
Enterprise Value
1.85B
1-Year Change
333.31%
Ranking
Category
Stock Price
$5.10
Market Cap Chart
Since August 8, 2013, Precigen's market cap has decreased from $2.32B to $1.82B, a decrease of -21.71%. That is a compound annual growth rate of -1.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 1.82B | 22.81% |
| Dec 31, 2025 | 1.48B | 350.91% |
| Dec 31, 2024 | 328.00M | -1.68% |
| Dec 29, 2023 | 333.60M | 5.44% |
| Dec 30, 2022 | 316.40M | -58.75% |
| Dec 31, 2021 | 767.00M | -59.45% |
| Dec 31, 2020 | 1.89B | 112.19% |
| Dec 31, 2019 | 891.50M | -0.66% |
| Dec 31, 2018 | 897.40M | -35.47% |
| Dec 29, 2017 | 1.39B | -51.74% |
| Dec 30, 2016 | 2.88B | -17.89% |
| Dec 31, 2015 | 3.51B | 26.82% |
| Dec 31, 2014 | 2.77B | 19.88% |
| Dec 31, 2013 | 2.31B | -0.51% |
| Aug 8, 2013 | 2.32B | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnaptysBio | 1.97B |
| Stoke Therapeutics | 1.95B |
| Tyra Biosciences | 1.95B |
| Monte Rosa Therapeutics | 1.95B |
| AtaiBeckley | 1.90B |
| Bicara Therapeutics | 1.90B |
| Recursion Pharmaceuticals | 1.89B |
| Iovance Biotherapeutics | 1.89B |